🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Save the dates: 29th & 30th May 2025. #EAU24 European Association of Urology (EAU) BAUS BSoT BURST Urology Amer. Urol. Assn. World Bladder Cancer Patient Coalition Come to #Edinburgh Come to #Scotland 12th Scottish #BladderCancer Symposium - High Risk NMIBC & MIBC. Some of the faculty:

📝📍finally out the first recommendations paper from the #GURetreat Ospedale San Raffaele Optimizing the use of NGS in pts with UC| Valentina Tateo Antonio Cigliola Chiara Mercinelli Neeraj Agarwal, MD, FASCO Petros Grivas Ashish M. Kamat, MD, MBBS Lars Dyrskjøt ylt Shilpa Gupta Philippe spiess clinical-genitourinary-cancer.com/article/S1558-…

IBCN 2024 REMINDER: The deadline for abstract submission is rapidly approaching! Abstracts must be submitted by May 31st. ibcnweb.com/abstracts/ Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt @JeffreyD_UNC

Philip H. Abbosh, Peter Kuhn, and #AACRbladder24 cochair Lars Dyrskjøt discussed "Liquid Biopsies for Guiding Treatment Decisions" in a plenary session this morning at the AACR Special Conference on Bladder Cancer. Phillip Abbosh Peter Kuhn Lars Dyrskjøt

***ONLY 1 WEEK LEFT*** The deadline to submit abstracts for IBCN2024 is rapidly approaching! Abstracts are due May 31st!! ibcnweb.com/abstracts/ Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt Jeffrey Damrauer

Molecular testing to guide peri-op management for urothelial cancer doi.org/10.1200/EDBK_4… Matt Galsky Pooja Ghatalia ASCO #ASCO24

Articles in Press: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma by Iver Nordentoft and Sia Viborg Lindskrog et al Read the full article here: europeanurology.com/article/S0302-… #UroSoMe #Medtwitter #BladderCa

Fantastic study on ctDNA published European Urology ! Congrats Lars Lars Dyrskjøt, Iver Nordentoft, Sia Viborg Lindskrog and all collaborators! Really important to further improve ctDNA diagnostics for UC! ctDNA will play an important role for tailoring treatment of MIBC (eg, bladder

Announcing faculty for The 12th Scottish Bladder Cancer Symposium: HR-NMIBC & MIBC Dates: 29th & 30th May 2025 Venue: The Royal College of Surgeons of Edinburgh Ashish M. Kamat, MD, MBBS Lars Dyrskjøt Jørgen Bjerggaard Prof Ananya💙 evacomperat 💙alison birtle Lydia Makaroff jim catto #FredWitjes #UroSoMe #BCAM25

Check out our recent commentary to the updated IMvigor010 #ctDNA study results which also includes our perspectives on the utility of ctDNA in MIBC and an overview of the currently ongoing ctDNA-guided trials in #bladdercancer: tau.amegroups.org/article/view/1… 🩸🧬

Only 2 weeks left to register for the 2024 IBCN Meeting!!! Meeting Details: ibcnweb.com/2024-ibcn-meet… Peter Black Lars Dyrskjøt Kent Mouw Roland Seiler-Blarer Tilman Todenhöfer Jeffrey Damrauer

Congratulations Andrea Apolo, M.D. and the @alliance team for the ph 3 Ambassador trial data showing improved disease free survival with pembrolizumab in MIBC after surgery #bladdercancer 👇Terrific presentation and Simultaneously published NEJM paper👇 ESMO - Eur. Oncology #ESMO24 OncoAlert

Excellent elegant presentation by Tom Powles Uromigos on biomarkers from EV302 practice changing trial! Nectin4 is not correlated with PDL1 or clinical outcomes! Awaiting more biomarker work from EV trials! ESMO - Eur. Oncology #ESMO24 #ESMOAmbassadors OncoAlert Neeraj Agarwal, MD, FASCO Toni Choueiri, MD